Chrome Extension
WeChat Mini Program
Use on ChatGLM

Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials

eBioMedicine(2022)

Cited 31|Views7
No score
Abstract
Bill & Melinda Gates Foundation, BIRAC-Division of Department of Biotechnology, Govt of India, and the Coalition for Epidemic Preparedness Innovations funded this study.
More
Translated text
Key words
Covid-19,Vaccine,Receptor-binding domain,SARS-CoV-2,Spike protein,Protein subunit
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined